Collaborative Arrangement Net Sales Tied To Know How Royalty
Alkermes·Products & Services·1 segment
Breakdown
Segments
OH Risperidone PalimateView metric
| Segment | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| OH Risperidone Palimate | $500M | $500M | $500M | $500M | $500M |
| Total | $500M | $500M | $500M | $500M | $500M |
All segment values are derived from annual filings.